Home Podcasts Diabetes Core Update
Diabetes Core Update

Diabetes Core Update

American Diabetes Association 100 Episodes Jun 30, 2026

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles in the field of diabetes research and care, including those from the American Diabetes Association's three science and health journals. Each episode is approximately 15 minutes long and covers 5-6 recently published articles from ADA journals and beyond. The podcast is intended for practicing physicians and health care professionals, discussing how the latest research and information can be applied in a treatment setting.

Episodes

Efficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more! Jun 30, 2026 34:30 Welcome to the latest episode (July 2026) of DOC Updates, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates: Aroda V, Buzzetti R, Dalskov S et al. "Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on di
Special Edition: Medications in the Pipeline for Cardiometabolic Disease Jun 25, 2026 25:10 In this special edition of DOC Updates, Neil Skolnik speaks with Dr. Juan Frias, who catalogues the latest cardiometabolic medications, emphasizing the distinguishing characteristics of each. This special episode is sponsored with support from Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Dir
Special Edition: The Diabetes, Obesity, and CardioMetabolic CARE Symposium—The Cost of Obesity and Its Treatment Jun 24, 2026 29:56 In this special episode of The Points of CARE, recorded live during the American Diabetes Association's (ADA) 2026 Scientific Sessions in New Orleans, hosts Richard Beaser, MD and Jane Reusch, MD highlight a new symposium on the clinical, social, and economic costs of treating—or not treating—individuals with obesity. This panel discussion is moderated by Louis J. Aronne, MD, Sanford I. Weill Prof
Anna Kahkoska & Joshua Niznik on Patient Portal Messages and Older Adults with T2D, Esben Thyssen Vestergaard on Clinic for Athletes with T1D, and more! Jun 10, 2026 38:08 With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through in
Food coloring additives & T2D, automated insulin delivery systems in T2D, and more! Jun 2, 2026 38:41 Welcome to the latest episode (June 2026) of Diabetes Core Update, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Update: Shah S, et al. "Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort Diabetes Care. 2026;49(6):1067–1077. doi.org/10.2
Special Edition: Obesity Processes and PATHWEIGH for Obesity Care May 29, 2026 30:00 In this special edition of Diabetes Core Update, Neil Skolnik discusses PATHWEIGH, a novel obesity care process for primary care clinicians which has demonstrated a decrease in population weight gain. This special episode is sponsored with support from Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Ass
Special Edition: Obesity—The Changing Landscape May 26, 2026 33:31 In the first episode of this series on Obesity, our host is joined by Dr. Mikhail Kosiborod to discuss the evolving science and cardiometabolic diseases associated with obesity. This special episode is sponsored with support from AstraZeneca. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, F
Special Edition: What's Next—Cortisol, Metabolism & Future Innovation, Part 4 May 19, 2026 27:06 Is hypercortisolism the hidden culprit in a significant proportion of both difficult-to-treat diabetes and resistant hypertension? In part 4 of our special series, Dr. Neil Skolnik speaks with John Buse, MD to explore the effects of hypercortisolism, until just recently considered a vanishingly rare condition. This special episode is sponsored with support from Corcept. Please listen to the episod
Special Edition: What's Next—Cardiovascular Risk in CKD—The Overlooked Burden May 12, 2026 30:56 We have only recently become aware of the close relationship between the heart and the kidneys. In today's discussion, Dr. Neil Skolnik speaks with Dr. Josephine Harrington to gain insight into these newly-discovered links between cardiovascular risk and CKD. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freel
Special Edition: What's Next—Once-Weekly Insulin May 5, 2026 20:46 In the early 2000s, long-acting, once-daily insulin was approved, completely changing the experience of using insulin for people with diabetes. But science doesn't stand still. Now the FDA has approved weekly insulin. In this special episode of Diabetes Core Update, Neil Skolnik speaks with Athena Philis-Tsimikas, MD about this exciting development. This special edition of Diabetes Core Update is
Associations between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy, Tirzepetide vs. Dulaglutide or Semaglutide on major cardiovascular events in T2D, and more! May 1, 2026 36:59 Welcome to the latest episode (May 2026) of Diabetes Core Update, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month, they discuss: Marston NA, Bohula EA, Bhatia AK, et al. "Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diab
Special Edition: What's Next—Emerging Technologies for People with Diabetes Apr 15, 2026 35:05 In this special edition on Emerging Technologies for People with Diabetes our host, Dr. Neil Skolnik will discuss recent and future advances in technologies for people with diabetes. This special episode is supported by an independent educational grant from Seagrove Partners. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jeffers

Recommended